Sarepta Therapeutics SRPT
NASDAQ SRPT
$16.50 +0.08 (+0.49%)
As of: Nov 11, 2026 · 1:23 PM EST

Sarepta Therapeutics (SRPT) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Sarepta Therapeutics (SRPT) recorded Return on Capital Employed [ROCE] of -5.34% in Q2 2026, down 5.31 percentage points from -0.04% a year earlier and down 3.86 percentage points from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Sarepta Therapeutics reported Return on Capital Employed [ROCE] of -27.32%, down 34.89 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +1.06 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 7.57% in FY2024 (+18.10 pp), -10.53% in FY2023 (+10.76 pp), -21.29% in FY2022 (-3.70 pp) and -17.59% in FY2021 (+10.79 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -30.08% in Q4 2025 to 7.15% in Q4 2024 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in three of the last eight quarters, with an average year-over-year change of -1.74 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 21.09 percentage points in Q2 2024, against a drop of 37.23 percentage points in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1.48% (Q1 2026), -30.08% (Q4 2025) and -4.75% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Sarepta Therapeutics 1.76 Bn -1.50 Bn 192.84 Mn -1.94%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1.94%
Jun 30, 2026 -5.34%
Mar 31, 2026 -1.48%
Dec 31, 2025 -30.08%
Sep 30, 2025 -4.75%
Jun 30, 2025 -0.04%
Mar 31, 2025 -3.77%
Dec 31, 2024 7.15%
Sep 30, 2024 2.88%
Jun 30, 2024 1.44%
Mar 31, 2024 -3.60%
Dec 31, 2023 -10.57%
Sep 30, 2023 -14.97%
Jun 30, 2023 -19.65%
Mar 31, 2023 -22.97%
Dec 31, 2022 -21.26%
Sep 30, 2022 -21.64%
Jun 30, 2022 -17.67%
Mar 31, 2022 -14.91%
Dec 31, 2021 -18.75%
API Access

Sarepta Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SRPT&period=max&api_key=YOUR_API_KEY